Zacks Investment Research on MSN
Pacira to divest iovera business to Zimmer Biomet in up to $140M deal
Pacira BioSciences PCRX is reshaping its business through an agreement to divest its iovera medical device franchise to ...
TAMPA, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...
Pacira to receive up to $140 million with $70 million upfront and up to an additional $70 million in potential future revenue-based milestone payments -- -- Two companies will collaborate on advancing ...
Lane Regional Medical Center is one of the first hospitals in the region to adopt Iovera technology, a clinically proven, nonopioid, pain management solution for relief of chronic and acute knee pain, ...
-- Beginning January 1, 2025, providers can receive additional Medicare payment when they use EXPAREL or iovera° via product-specific reimbursement codes -- PARSIPPANY, N.J., Nov. 04, 2024 (GLOBE ...
Using the correct current procedural terminology (CPT) codes is crucial for documenting — and getting reimbursement for — novel treatments for which there is specific but narrowly defined guidance.
In 2021, it was estimated that about 23% of adults living in Las Vegas, NV had arthritis. Osteoarthritis (OA), the most common form of arthritis, affects millions of people worldwide. OA symptoms can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results